Covid-19 Impact on Global Anti-Neoplastic Pharmaceutical Agents Market Size, Status and Forecast 2020-2026
Anti-neoplastic are the drugs that prevent growth of any abnormal tissue leading to cancer. The drugs pass into the human body and destroy cancerous cells. These drugs are also used in conjunction with surgery, radiotherapy and immunotherapy for solid tumors. The anti-neoplastic pharmaceutical agents are also known as cytotoxic agents .The changing lifestyle across the globe is increasing the chances of cancer which leads to high demand for the anti-neoplastic pharmaceutical agents from pharmaceutical companies.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Anti-Neoplastic Pharmaceutical Agents market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Anti-Neoplastic Pharmaceutical Agents industry.
Based on our recent survey, we have several different scenarios about the Anti-Neoplastic Pharmaceutical Agents YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Anti-Neoplastic Pharmaceutical Agents will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anti-Neoplastic Pharmaceutical Agents market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anti-Neoplastic Pharmaceutical Agents market in terms of revenue.
Players, stakeholders, and other participants in the global Anti-Neoplastic Pharmaceutical Agents market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Anti-Neoplastic Pharmaceutical Agents market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Anti-Neoplastic Pharmaceutical Agents market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anti-Neoplastic Pharmaceutical Agents market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anti-Neoplastic Pharmaceutical Agents market.
The following players are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Anti-Neoplastic Pharmaceutical Agents market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Anti-Neoplastic Pharmaceutical Agents industry.
Based on our recent survey, we have several different scenarios about the Anti-Neoplastic Pharmaceutical Agents YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Anti-Neoplastic Pharmaceutical Agents will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anti-Neoplastic Pharmaceutical Agents market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anti-Neoplastic Pharmaceutical Agents market in terms of revenue.
Players, stakeholders, and other participants in the global Anti-Neoplastic Pharmaceutical Agents market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Anti-Neoplastic Pharmaceutical Agents market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Anti-Neoplastic Pharmaceutical Agents market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anti-Neoplastic Pharmaceutical Agents market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anti-Neoplastic Pharmaceutical Agents market.
The following players are covered in this report:
- GlaxoSmithKline plc.
- F. Hoffmann-La Roche Ltd
- Eli Lilly and Company
- Bristol-Myers Squibb Company
- Becton, Dickinson and Company
- Pfizer Inc.
- Novartis AG
- AstraZeneca
- Gilead
- Hormones and Antagonists
- Microorganism Products
- Plant Products
- Antitumor Antibiotics
- Alkylating Agents
- Antimetabolites
- Natural Products
- Lung Cancer
- Bladder Cancer
- Breast Cancer
- Cervical Cancer
- Leukemia
- Gynecological Cancer
- Other
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Anti-Neoplastic Pharmaceutical Agents Revenue
1.4 Market Analysis by Type
1.4.1 Global Anti-Neoplastic Pharmaceutical Agents Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Hormones and Antagonists
1.4.3 Microorganism Products
1.4.4 Plant Products
1.4.5 Antitumor Antibiotics
1.4.6 Alkylating Agents
1.4.7 Antimetabolites
1.4.8 Natural Products
1.5 Market by Application
1.5.1 Global Anti-Neoplastic Pharmaceutical Agents Market Share by Application: 2020 VS 2026
1.5.2 Lung Cancer
1.5.3 Bladder Cancer
1.5.4 Breast Cancer
1.5.5 Cervical Cancer
1.5.6 Leukemia
1.5.7 Gynecological Cancer
1.5.8 Other
1.6 Coronavirus Disease 2019 (Covid-19): Anti-Neoplastic Pharmaceutical Agents Industry Impact
1.6.1 How the Covid-19 is Affecting the Anti-Neoplastic Pharmaceutical Agents Industry
1.6.1.1 Anti-Neoplastic Pharmaceutical Agents Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Anti-Neoplastic Pharmaceutical Agents Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Anti-Neoplastic Pharmaceutical Agents Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Anti-Neoplastic Pharmaceutical Agents Market Perspective (2015-2026)
2.2 Anti-Neoplastic Pharmaceutical Agents Growth Trends by Regions
2.2.1 Anti-Neoplastic Pharmaceutical Agents Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Anti-Neoplastic Pharmaceutical Agents Historic Market Share by Regions (2015-2020)
2.2.3 Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Anti-Neoplastic Pharmaceutical Agents Market Growth Strategy
2.3.6 Primary Interviews with Key Anti-Neoplastic Pharmaceutical Agents Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Anti-Neoplastic Pharmaceutical Agents Players by Market Size
3.1.1 Global Top Anti-Neoplastic Pharmaceutical Agents Players by Revenue (2015-2020)
3.1.2 Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Players (2015-2020)
3.1.3 Global Anti-Neoplastic Pharmaceutical Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Anti-Neoplastic Pharmaceutical Agents Market Concentration Ratio
3.2.1 Global Anti-Neoplastic Pharmaceutical Agents Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Anti-Neoplastic Pharmaceutical Agents Revenue in 2019
3.3 Anti-Neoplastic Pharmaceutical Agents Key Players Head office and Area Served
3.4 Key Players Anti-Neoplastic Pharmaceutical Agents Product Solution and Service
3.5 Date of Enter into Anti-Neoplastic Pharmaceutical Agents Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Anti-Neoplastic Pharmaceutical Agents Historic Market Size by Type (2015-2020)
4.2 Global Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Type (2021-2026)
5 ANTI-NEOPLASTIC PHARMACEUTICAL AGENTS BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020)
5.2 Global Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Anti-Neoplastic Pharmaceutical Agents Market Size (2015-2020)
6.2 Anti-Neoplastic Pharmaceutical Agents Key Players in North America (2019-2020)
6.3 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020)
6.4 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Anti-Neoplastic Pharmaceutical Agents Market Size (2015-2020)
7.2 Anti-Neoplastic Pharmaceutical Agents Key Players in Europe (2019-2020)
7.3 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020)
7.4 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020)
8 CHINA
8.1 China Anti-Neoplastic Pharmaceutical Agents Market Size (2015-2020)
8.2 Anti-Neoplastic Pharmaceutical Agents Key Players in China (2019-2020)
8.3 China Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020)
8.4 China Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Anti-Neoplastic Pharmaceutical Agents Market Size (2015-2020)
9.2 Anti-Neoplastic Pharmaceutical Agents Key Players in Japan (2019-2020)
9.3 Japan Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020)
9.4 Japan Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Size (2015-2020)
10.2 Anti-Neoplastic Pharmaceutical Agents Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020)
10.4 Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020)
11 INDIA
11.1 India Anti-Neoplastic Pharmaceutical Agents Market Size (2015-2020)
11.2 Anti-Neoplastic Pharmaceutical Agents Key Players in India (2019-2020)
11.3 India Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020)
11.4 India Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Anti-Neoplastic Pharmaceutical Agents Market Size (2015-2020)
12.2 Anti-Neoplastic Pharmaceutical Agents Key Players in Central & South America (2019-2020)
12.3 Central & South America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020)
12.4 Central & South America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 GlaxoSmithKline plc.
13.1.1 GlaxoSmithKline plc. Company Details
13.1.2 GlaxoSmithKline plc. Business Overview and Its Total Revenue
13.1.3 GlaxoSmithKline plc. Anti-Neoplastic Pharmaceutical Agents Introduction
13.1.4 GlaxoSmithKline plc. Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020))
13.1.5 GlaxoSmithKline plc. Recent Development
13.2 F. Hoffmann-La Roche Ltd
13.2.1 F. Hoffmann-La Roche Ltd Company Details
13.2.2 F. Hoffmann-La Roche Ltd Business Overview and Its Total Revenue
13.2.3 F. Hoffmann-La Roche Ltd Anti-Neoplastic Pharmaceutical Agents Introduction
13.2.4 F. Hoffmann-La Roche Ltd Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
13.2.5 F. Hoffmann-La Roche Ltd Recent Development
13.3 Eli Lilly and Company
13.3.1 Eli Lilly and Company Company Details
13.3.2 Eli Lilly and Company Business Overview and Its Total Revenue
13.3.3 Eli Lilly and Company Anti-Neoplastic Pharmaceutical Agents Introduction
13.3.4 Eli Lilly and Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
13.3.5 Eli Lilly and Company Recent Development
13.4 Bristol-Myers Squibb Company
13.4.1 Bristol-Myers Squibb Company Company Details
13.4.2 Bristol-Myers Squibb Company Business Overview and Its Total Revenue
13.4.3 Bristol-Myers Squibb Company Anti-Neoplastic Pharmaceutical Agents Introduction
13.4.4 Bristol-Myers Squibb Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
13.4.5 Bristol-Myers Squibb Company Recent Development
13.5 Becton, Dickinson and Company
13.5.1 Becton, Dickinson and Company Company Details
13.5.2 Becton, Dickinson and Company Business Overview and Its Total Revenue
13.5.3 Becton, Dickinson and Company Anti-Neoplastic Pharmaceutical Agents Introduction
13.5.4 Becton, Dickinson and Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
13.5.5 Becton, Dickinson and Company Recent Development
13.6 Pfizer Inc.
13.6.1 Pfizer Inc. Company Details
13.6.2 Pfizer Inc. Business Overview and Its Total Revenue
13.6.3 Pfizer Inc. Anti-Neoplastic Pharmaceutical Agents Introduction
13.6.4 Pfizer Inc. Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
13.6.5 Pfizer Inc. Recent Development
13.7 Novartis AG
13.7.1 Novartis AG Company Details
13.7.2 Novartis AG Business Overview and Its Total Revenue
13.7.3 Novartis AG Anti-Neoplastic Pharmaceutical Agents Introduction
13.7.4 Novartis AG Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
13.7.5 Novartis AG Recent Development
13.8 AstraZeneca
13.8.1 AstraZeneca Company Details
13.8.2 AstraZeneca Business Overview and Its Total Revenue
13.8.3 AstraZeneca Anti-Neoplastic Pharmaceutical Agents Introduction
13.8.4 AstraZeneca Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
13.8.5 AstraZeneca Recent Development
13.9 Gilead
13.9.1 Gilead Company Details
13.9.2 Gilead Business Overview and Its Total Revenue
13.9.3 Gilead Anti-Neoplastic Pharmaceutical Agents Introduction
13.9.4 Gilead Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
13.9.5 Gilead Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Anti-Neoplastic Pharmaceutical Agents Revenue
1.4 Market Analysis by Type
1.4.1 Global Anti-Neoplastic Pharmaceutical Agents Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Hormones and Antagonists
1.4.3 Microorganism Products
1.4.4 Plant Products
1.4.5 Antitumor Antibiotics
1.4.6 Alkylating Agents
1.4.7 Antimetabolites
1.4.8 Natural Products
1.5 Market by Application
1.5.1 Global Anti-Neoplastic Pharmaceutical Agents Market Share by Application: 2020 VS 2026
1.5.2 Lung Cancer
1.5.3 Bladder Cancer
1.5.4 Breast Cancer
1.5.5 Cervical Cancer
1.5.6 Leukemia
1.5.7 Gynecological Cancer
1.5.8 Other
1.6 Coronavirus Disease 2019 (Covid-19): Anti-Neoplastic Pharmaceutical Agents Industry Impact
1.6.1 How the Covid-19 is Affecting the Anti-Neoplastic Pharmaceutical Agents Industry
1.6.1.1 Anti-Neoplastic Pharmaceutical Agents Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Anti-Neoplastic Pharmaceutical Agents Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Anti-Neoplastic Pharmaceutical Agents Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Anti-Neoplastic Pharmaceutical Agents Market Perspective (2015-2026)
2.2 Anti-Neoplastic Pharmaceutical Agents Growth Trends by Regions
2.2.1 Anti-Neoplastic Pharmaceutical Agents Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Anti-Neoplastic Pharmaceutical Agents Historic Market Share by Regions (2015-2020)
2.2.3 Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Anti-Neoplastic Pharmaceutical Agents Market Growth Strategy
2.3.6 Primary Interviews with Key Anti-Neoplastic Pharmaceutical Agents Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Anti-Neoplastic Pharmaceutical Agents Players by Market Size
3.1.1 Global Top Anti-Neoplastic Pharmaceutical Agents Players by Revenue (2015-2020)
3.1.2 Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Players (2015-2020)
3.1.3 Global Anti-Neoplastic Pharmaceutical Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Anti-Neoplastic Pharmaceutical Agents Market Concentration Ratio
3.2.1 Global Anti-Neoplastic Pharmaceutical Agents Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Anti-Neoplastic Pharmaceutical Agents Revenue in 2019
3.3 Anti-Neoplastic Pharmaceutical Agents Key Players Head office and Area Served
3.4 Key Players Anti-Neoplastic Pharmaceutical Agents Product Solution and Service
3.5 Date of Enter into Anti-Neoplastic Pharmaceutical Agents Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Anti-Neoplastic Pharmaceutical Agents Historic Market Size by Type (2015-2020)
4.2 Global Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Type (2021-2026)
5 ANTI-NEOPLASTIC PHARMACEUTICAL AGENTS BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020)
5.2 Global Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Anti-Neoplastic Pharmaceutical Agents Market Size (2015-2020)
6.2 Anti-Neoplastic Pharmaceutical Agents Key Players in North America (2019-2020)
6.3 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020)
6.4 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Anti-Neoplastic Pharmaceutical Agents Market Size (2015-2020)
7.2 Anti-Neoplastic Pharmaceutical Agents Key Players in Europe (2019-2020)
7.3 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020)
7.4 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020)
8 CHINA
8.1 China Anti-Neoplastic Pharmaceutical Agents Market Size (2015-2020)
8.2 Anti-Neoplastic Pharmaceutical Agents Key Players in China (2019-2020)
8.3 China Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020)
8.4 China Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Anti-Neoplastic Pharmaceutical Agents Market Size (2015-2020)
9.2 Anti-Neoplastic Pharmaceutical Agents Key Players in Japan (2019-2020)
9.3 Japan Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020)
9.4 Japan Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Size (2015-2020)
10.2 Anti-Neoplastic Pharmaceutical Agents Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020)
10.4 Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020)
11 INDIA
11.1 India Anti-Neoplastic Pharmaceutical Agents Market Size (2015-2020)
11.2 Anti-Neoplastic Pharmaceutical Agents Key Players in India (2019-2020)
11.3 India Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020)
11.4 India Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Anti-Neoplastic Pharmaceutical Agents Market Size (2015-2020)
12.2 Anti-Neoplastic Pharmaceutical Agents Key Players in Central & South America (2019-2020)
12.3 Central & South America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020)
12.4 Central & South America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 GlaxoSmithKline plc.
13.1.1 GlaxoSmithKline plc. Company Details
13.1.2 GlaxoSmithKline plc. Business Overview and Its Total Revenue
13.1.3 GlaxoSmithKline plc. Anti-Neoplastic Pharmaceutical Agents Introduction
13.1.4 GlaxoSmithKline plc. Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020))
13.1.5 GlaxoSmithKline plc. Recent Development
13.2 F. Hoffmann-La Roche Ltd
13.2.1 F. Hoffmann-La Roche Ltd Company Details
13.2.2 F. Hoffmann-La Roche Ltd Business Overview and Its Total Revenue
13.2.3 F. Hoffmann-La Roche Ltd Anti-Neoplastic Pharmaceutical Agents Introduction
13.2.4 F. Hoffmann-La Roche Ltd Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
13.2.5 F. Hoffmann-La Roche Ltd Recent Development
13.3 Eli Lilly and Company
13.3.1 Eli Lilly and Company Company Details
13.3.2 Eli Lilly and Company Business Overview and Its Total Revenue
13.3.3 Eli Lilly and Company Anti-Neoplastic Pharmaceutical Agents Introduction
13.3.4 Eli Lilly and Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
13.3.5 Eli Lilly and Company Recent Development
13.4 Bristol-Myers Squibb Company
13.4.1 Bristol-Myers Squibb Company Company Details
13.4.2 Bristol-Myers Squibb Company Business Overview and Its Total Revenue
13.4.3 Bristol-Myers Squibb Company Anti-Neoplastic Pharmaceutical Agents Introduction
13.4.4 Bristol-Myers Squibb Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
13.4.5 Bristol-Myers Squibb Company Recent Development
13.5 Becton, Dickinson and Company
13.5.1 Becton, Dickinson and Company Company Details
13.5.2 Becton, Dickinson and Company Business Overview and Its Total Revenue
13.5.3 Becton, Dickinson and Company Anti-Neoplastic Pharmaceutical Agents Introduction
13.5.4 Becton, Dickinson and Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
13.5.5 Becton, Dickinson and Company Recent Development
13.6 Pfizer Inc.
13.6.1 Pfizer Inc. Company Details
13.6.2 Pfizer Inc. Business Overview and Its Total Revenue
13.6.3 Pfizer Inc. Anti-Neoplastic Pharmaceutical Agents Introduction
13.6.4 Pfizer Inc. Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
13.6.5 Pfizer Inc. Recent Development
13.7 Novartis AG
13.7.1 Novartis AG Company Details
13.7.2 Novartis AG Business Overview and Its Total Revenue
13.7.3 Novartis AG Anti-Neoplastic Pharmaceutical Agents Introduction
13.7.4 Novartis AG Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
13.7.5 Novartis AG Recent Development
13.8 AstraZeneca
13.8.1 AstraZeneca Company Details
13.8.2 AstraZeneca Business Overview and Its Total Revenue
13.8.3 AstraZeneca Anti-Neoplastic Pharmaceutical Agents Introduction
13.8.4 AstraZeneca Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
13.8.5 AstraZeneca Recent Development
13.9 Gilead
13.9.1 Gilead Company Details
13.9.2 Gilead Business Overview and Its Total Revenue
13.9.3 Gilead Anti-Neoplastic Pharmaceutical Agents Introduction
13.9.4 Gilead Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
13.9.5 Gilead Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Anti-Neoplastic Pharmaceutical Agents Key Market Segments
Table 2. Key Players Covered: Ranking by Anti-Neoplastic Pharmaceutical Agents Revenue
Table 3. Ranking of Global Top Anti-Neoplastic Pharmaceutical Agents Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Anti-Neoplastic Pharmaceutical Agents Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Hormones and Antagonists
Table 6. Key Players of Microorganism Products
Table 7. Key Players of Plant Products
Table 8. Key Players of Antitumor Antibiotics
Table 9. Key Players of Alkylating Agents
Table 10. Key Players of Antimetabolites
Table 11. Key Players of Natural Products
Table 12. COVID-19 Impact Global Market: (Four Anti-Neoplastic Pharmaceutical Agents Market Size Forecast Scenarios)
Table 13. Opportunities and Trends for Anti-Neoplastic Pharmaceutical Agents Players in the COVID-19 Landscape
Table 14. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 15. Key Regions/Countries Measures against Covid-19 Impact
Table 16. Proposal for Anti-Neoplastic Pharmaceutical Agents Players to Combat Covid-19 Impact
Table 17. Global Anti-Neoplastic Pharmaceutical Agents Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 18. Global Anti-Neoplastic Pharmaceutical Agents Market Size by Regions (US$ Million): 2020 VS 2026
Table 19. Global Anti-Neoplastic Pharmaceutical Agents Market Size by Regions (2015-2020) (US$ Million)
Table 20. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Regions (2015-2020)
Table 21. Global Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 22. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Regions (2021-2026)
Table 23. Market Top Trends
Table 24. Key Drivers: Impact Analysis
Table 25. Key Challenges
Table 26. Anti-Neoplastic Pharmaceutical Agents Market Growth Strategy
Table 27. Main Points Interviewed from Key Anti-Neoplastic Pharmaceutical Agents Players
Table 28. Global Anti-Neoplastic Pharmaceutical Agents Revenue by Players (2015-2020) (Million US$)
Table 29. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Players (2015-2020)
Table 30. Global Top Anti-Neoplastic Pharmaceutical Agents Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Neoplastic Pharmaceutical Agents as of 2019)
Table 31. Global Anti-Neoplastic Pharmaceutical Agents by Players Market Concentration Ratio (CR5 and HHI)
Table 32. Key Players Headquarters and Area Served
Table 33. Key Players Anti-Neoplastic Pharmaceutical Agents Product Solution and Service
Table 34. Date of Enter into Anti-Neoplastic Pharmaceutical Agents Market
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) (Million US$)
Table 37. Global Anti-Neoplastic Pharmaceutical Agents Market Size Share by Type (2015-2020)
Table 38. Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Type (2021-2026)
Table 39. Global Anti-Neoplastic Pharmaceutical Agents Market Size Share by Application (2015-2020)
Table 40. Global Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) (Million US$)
Table 41. Global Anti-Neoplastic Pharmaceutical Agents Market Size Share by Application (2021-2026)
Table 42. North America Key Players Anti-Neoplastic Pharmaceutical Agents Revenue (2019-2020) (Million US$)
Table 43. North America Key Players Anti-Neoplastic Pharmaceutical Agents Market Share (2019-2020)
Table 44. North America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) (Million US$)
Table 45. North America Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2015-2020)
Table 46. North America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) (Million US$)
Table 47. North America Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2015-2020)
Table 48. Europe Key Players Anti-Neoplastic Pharmaceutical Agents Revenue (2019-2020) (Million US$)
Table 49. Europe Key Players Anti-Neoplastic Pharmaceutical Agents Market Share (2019-2020)
Table 50. Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) (Million US$)
Table 51. Europe Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2015-2020)
Table 52. Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) (Million US$)
Table 53. Europe Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2015-2020)
Table 54. China Key Players Anti-Neoplastic Pharmaceutical Agents Revenue (2019-2020) (Million US$)
Table 55. China Key Players Anti-Neoplastic Pharmaceutical Agents Market Share (2019-2020)
Table 56. China Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) (Million US$)
Table 57. China Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2015-2020)
Table 58. China Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) (Million US$)
Table 59. China Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2015-2020)
Table 60. Japan Key Players Anti-Neoplastic Pharmaceutical Agents Revenue (2019-2020) (Million US$)
Table 61. Japan Key Players Anti-Neoplastic Pharmaceutical Agents Market Share (2019-2020)
Table 62. Japan Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) (Million US$)
Table 63. Japan Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2015-2020)
Table 64. Japan Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) (Million US$)
Table 65. Japan Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2015-2020)
Table 66. Southeast Asia Key Players Anti-Neoplastic Pharmaceutical Agents Revenue (2019-2020) (Million US$)
Table 67. Southeast Asia Key Players Anti-Neoplastic Pharmaceutical Agents Market Share (2019-2020)
Table 68. Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) (Million US$)
Table 69. Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2015-2020)
Table 70. Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) (Million US$)
Table 71. Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2015-2020)
Table 72. India Key Players Anti-Neoplastic Pharmaceutical Agents Revenue (2019-2020) (Million US$)
Table 73. India Key Players Anti-Neoplastic Pharmaceutical Agents Market Share (2019-2020)
Table 74. India Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) (Million US$)
Table 75. India Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2015-2020)
Table 76. India Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) (Million US$)
Table 77. India Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2015-2020)
Table 78. Central & South America Key Players Anti-Neoplastic Pharmaceutical Agents Revenue (2019-2020) (Million US$)
Table 79. Central & South America Key Players Anti-Neoplastic Pharmaceutical Agents Market Share (2019-2020)
Table 80. Central & South America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) (Million US$)
Table 81. Central & South America Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2015-2020)
Table 82. Central & South America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) (Million US$)
Table 83. Central & South America Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2015-2020)
Table 84. GlaxoSmithKline plc. Company Details
Table 85. GlaxoSmithKline plc. Business Overview
Table 86. GlaxoSmithKline plc. Product
Table 87. GlaxoSmithKline plc. Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) (Million US$)
Table 88. GlaxoSmithKline plc. Recent Development
Table 89. F. Hoffmann-La Roche Ltd Company Details
Table 90. F. Hoffmann-La Roche Ltd Business Overview
Table 91. F. Hoffmann-La Roche Ltd Product
Table 92. F. Hoffmann-La Roche Ltd Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) (Million US$)
Table 93. F. Hoffmann-La Roche Ltd Recent Development
Table 94. Eli Lilly and Company Company Details
Table 95. Eli Lilly and Company Business Overview
Table 96. Eli Lilly and Company Product
Table 97. Eli Lilly and Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) (Million US$)
Table 98. Eli Lilly and Company Recent Development
Table 99. Bristol-Myers Squibb Company Company Details
Table 100. Bristol-Myers Squibb Company Business Overview
Table 101. Bristol-Myers Squibb Company Product
Table 102. Bristol-Myers Squibb Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) (Million US$)
Table 103. Bristol-Myers Squibb Company Recent Development
Table 104. Becton, Dickinson and Company Company Details
Table 105. Becton, Dickinson and Company Business Overview
Table 106. Becton, Dickinson and Company Product
Table 107. Becton, Dickinson and Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) (Million US$)
Table 108. Becton, Dickinson and Company Recent Development
Table 109. Pfizer Inc. Company Details
Table 110. Pfizer Inc. Business Overview
Table 111. Pfizer Inc. Product
Table 112. Pfizer Inc. Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) (Million US$)
Table 113. Pfizer Inc. Recent Development
Table 114. Novartis AG Company Details
Table 115. Novartis AG Business Overview
Table 116. Novartis AG Product
Table 117. Novartis AG Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) (Million US$)
Table 118. Novartis AG Recent Development
Table 119. AstraZeneca Business Overview
Table 120. AstraZeneca Product
Table 121. AstraZeneca Company Details
Table 122. AstraZeneca Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) (Million US$)
Table 123. AstraZeneca Recent Development
Table 124. Gilead Company Details
Table 125. Gilead Business Overview
Table 126. Gilead Product
Table 127. Gilead Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) (Million US$)
Table 128. Gilead Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
Table 1. Anti-Neoplastic Pharmaceutical Agents Key Market Segments
Table 2. Key Players Covered: Ranking by Anti-Neoplastic Pharmaceutical Agents Revenue
Table 3. Ranking of Global Top Anti-Neoplastic Pharmaceutical Agents Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Anti-Neoplastic Pharmaceutical Agents Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Hormones and Antagonists
Table 6. Key Players of Microorganism Products
Table 7. Key Players of Plant Products
Table 8. Key Players of Antitumor Antibiotics
Table 9. Key Players of Alkylating Agents
Table 10. Key Players of Antimetabolites
Table 11. Key Players of Natural Products
Table 12. COVID-19 Impact Global Market: (Four Anti-Neoplastic Pharmaceutical Agents Market Size Forecast Scenarios)
Table 13. Opportunities and Trends for Anti-Neoplastic Pharmaceutical Agents Players in the COVID-19 Landscape
Table 14. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 15. Key Regions/Countries Measures against Covid-19 Impact
Table 16. Proposal for Anti-Neoplastic Pharmaceutical Agents Players to Combat Covid-19 Impact
Table 17. Global Anti-Neoplastic Pharmaceutical Agents Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 18. Global Anti-Neoplastic Pharmaceutical Agents Market Size by Regions (US$ Million): 2020 VS 2026
Table 19. Global Anti-Neoplastic Pharmaceutical Agents Market Size by Regions (2015-2020) (US$ Million)
Table 20. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Regions (2015-2020)
Table 21. Global Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 22. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Regions (2021-2026)
Table 23. Market Top Trends
Table 24. Key Drivers: Impact Analysis
Table 25. Key Challenges
Table 26. Anti-Neoplastic Pharmaceutical Agents Market Growth Strategy
Table 27. Main Points Interviewed from Key Anti-Neoplastic Pharmaceutical Agents Players
Table 28. Global Anti-Neoplastic Pharmaceutical Agents Revenue by Players (2015-2020) (Million US$)
Table 29. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Players (2015-2020)
Table 30. Global Top Anti-Neoplastic Pharmaceutical Agents Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Neoplastic Pharmaceutical Agents as of 2019)
Table 31. Global Anti-Neoplastic Pharmaceutical Agents by Players Market Concentration Ratio (CR5 and HHI)
Table 32. Key Players Headquarters and Area Served
Table 33. Key Players Anti-Neoplastic Pharmaceutical Agents Product Solution and Service
Table 34. Date of Enter into Anti-Neoplastic Pharmaceutical Agents Market
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) (Million US$)
Table 37. Global Anti-Neoplastic Pharmaceutical Agents Market Size Share by Type (2015-2020)
Table 38. Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Type (2021-2026)
Table 39. Global Anti-Neoplastic Pharmaceutical Agents Market Size Share by Application (2015-2020)
Table 40. Global Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) (Million US$)
Table 41. Global Anti-Neoplastic Pharmaceutical Agents Market Size Share by Application (2021-2026)
Table 42. North America Key Players Anti-Neoplastic Pharmaceutical Agents Revenue (2019-2020) (Million US$)
Table 43. North America Key Players Anti-Neoplastic Pharmaceutical Agents Market Share (2019-2020)
Table 44. North America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) (Million US$)
Table 45. North America Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2015-2020)
Table 46. North America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) (Million US$)
Table 47. North America Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2015-2020)
Table 48. Europe Key Players Anti-Neoplastic Pharmaceutical Agents Revenue (2019-2020) (Million US$)
Table 49. Europe Key Players Anti-Neoplastic Pharmaceutical Agents Market Share (2019-2020)
Table 50. Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) (Million US$)
Table 51. Europe Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2015-2020)
Table 52. Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) (Million US$)
Table 53. Europe Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2015-2020)
Table 54. China Key Players Anti-Neoplastic Pharmaceutical Agents Revenue (2019-2020) (Million US$)
Table 55. China Key Players Anti-Neoplastic Pharmaceutical Agents Market Share (2019-2020)
Table 56. China Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) (Million US$)
Table 57. China Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2015-2020)
Table 58. China Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) (Million US$)
Table 59. China Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2015-2020)
Table 60. Japan Key Players Anti-Neoplastic Pharmaceutical Agents Revenue (2019-2020) (Million US$)
Table 61. Japan Key Players Anti-Neoplastic Pharmaceutical Agents Market Share (2019-2020)
Table 62. Japan Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) (Million US$)
Table 63. Japan Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2015-2020)
Table 64. Japan Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) (Million US$)
Table 65. Japan Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2015-2020)
Table 66. Southeast Asia Key Players Anti-Neoplastic Pharmaceutical Agents Revenue (2019-2020) (Million US$)
Table 67. Southeast Asia Key Players Anti-Neoplastic Pharmaceutical Agents Market Share (2019-2020)
Table 68. Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) (Million US$)
Table 69. Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2015-2020)
Table 70. Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) (Million US$)
Table 71. Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2015-2020)
Table 72. India Key Players Anti-Neoplastic Pharmaceutical Agents Revenue (2019-2020) (Million US$)
Table 73. India Key Players Anti-Neoplastic Pharmaceutical Agents Market Share (2019-2020)
Table 74. India Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) (Million US$)
Table 75. India Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2015-2020)
Table 76. India Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) (Million US$)
Table 77. India Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2015-2020)
Table 78. Central & South America Key Players Anti-Neoplastic Pharmaceutical Agents Revenue (2019-2020) (Million US$)
Table 79. Central & South America Key Players Anti-Neoplastic Pharmaceutical Agents Market Share (2019-2020)
Table 80. Central & South America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) (Million US$)
Table 81. Central & South America Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2015-2020)
Table 82. Central & South America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) (Million US$)
Table 83. Central & South America Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2015-2020)
Table 84. GlaxoSmithKline plc. Company Details
Table 85. GlaxoSmithKline plc. Business Overview
Table 86. GlaxoSmithKline plc. Product
Table 87. GlaxoSmithKline plc. Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) (Million US$)
Table 88. GlaxoSmithKline plc. Recent Development
Table 89. F. Hoffmann-La Roche Ltd Company Details
Table 90. F. Hoffmann-La Roche Ltd Business Overview
Table 91. F. Hoffmann-La Roche Ltd Product
Table 92. F. Hoffmann-La Roche Ltd Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) (Million US$)
Table 93. F. Hoffmann-La Roche Ltd Recent Development
Table 94. Eli Lilly and Company Company Details
Table 95. Eli Lilly and Company Business Overview
Table 96. Eli Lilly and Company Product
Table 97. Eli Lilly and Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) (Million US$)
Table 98. Eli Lilly and Company Recent Development
Table 99. Bristol-Myers Squibb Company Company Details
Table 100. Bristol-Myers Squibb Company Business Overview
Table 101. Bristol-Myers Squibb Company Product
Table 102. Bristol-Myers Squibb Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) (Million US$)
Table 103. Bristol-Myers Squibb Company Recent Development
Table 104. Becton, Dickinson and Company Company Details
Table 105. Becton, Dickinson and Company Business Overview
Table 106. Becton, Dickinson and Company Product
Table 107. Becton, Dickinson and Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) (Million US$)
Table 108. Becton, Dickinson and Company Recent Development
Table 109. Pfizer Inc. Company Details
Table 110. Pfizer Inc. Business Overview
Table 111. Pfizer Inc. Product
Table 112. Pfizer Inc. Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) (Million US$)
Table 113. Pfizer Inc. Recent Development
Table 114. Novartis AG Company Details
Table 115. Novartis AG Business Overview
Table 116. Novartis AG Product
Table 117. Novartis AG Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) (Million US$)
Table 118. Novartis AG Recent Development
Table 119. AstraZeneca Business Overview
Table 120. AstraZeneca Product
Table 121. AstraZeneca Company Details
Table 122. AstraZeneca Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) (Million US$)
Table 123. AstraZeneca Recent Development
Table 124. Gilead Company Details
Table 125. Gilead Business Overview
Table 126. Gilead Product
Table 127. Gilead Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) (Million US$)
Table 128. Gilead Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Type: 2020 VS 2026
Figure 2. Hormones and Antagonists Features
Figure 3. Microorganism Products Features
Figure 4. Plant Products Features
Figure 5. Antitumor Antibiotics Features
Figure 6. Alkylating Agents Features
Figure 7. Antimetabolites Features
Figure 8. Natural Products Features
Figure 9. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Application: 2020 VS 2026
Figure 10. Lung Cancer Case Studies
Figure 11. Bladder Cancer Case Studies
Figure 12. Breast Cancer Case Studies
Figure 13. Cervical Cancer Case Studies
Figure 14. Leukemia Case Studies
Figure 15. Gynecological Cancer Case Studies
Figure 16. Other Case Studies
Figure 17. Anti-Neoplastic Pharmaceutical Agents Report Years Considered
Figure 18. Global Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth 2015-2026 (US$ Million)
Figure 19. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Regions: 2020 VS 2026
Figure 20. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Regions (2021-2026)
Figure 21. Porter's Five Forces Analysis
Figure 22. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Players in 2019
Figure 23. Global Top Anti-Neoplastic Pharmaceutical Agents Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Neoplastic Pharmaceutical Agents as of 2019
Figure 24. The Top 10 and 5 Players Market Share by Anti-Neoplastic Pharmaceutical Agents Revenue in 2019
Figure 25. North America Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Europe Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. China Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Japan Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. India Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2020) (Million US$)
Figure 31. Central & South America Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2020) (Million US$)
Figure 32. GlaxoSmithKline plc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. GlaxoSmithKline plc. Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
Figure 34. F. Hoffmann-La Roche Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
Figure 36. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Eli Lilly and Company Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
Figure 38. Bristol-Myers Squibb Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Bristol-Myers Squibb Company Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
Figure 40. Becton, Dickinson and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Becton, Dickinson and Company Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
Figure 42. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Pfizer Inc. Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
Figure 44. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Novartis AG Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
Figure 46. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. AstraZeneca Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
Figure 48. Gilead Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Gilead Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Figure 1. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Type: 2020 VS 2026
Figure 2. Hormones and Antagonists Features
Figure 3. Microorganism Products Features
Figure 4. Plant Products Features
Figure 5. Antitumor Antibiotics Features
Figure 6. Alkylating Agents Features
Figure 7. Antimetabolites Features
Figure 8. Natural Products Features
Figure 9. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Application: 2020 VS 2026
Figure 10. Lung Cancer Case Studies
Figure 11. Bladder Cancer Case Studies
Figure 12. Breast Cancer Case Studies
Figure 13. Cervical Cancer Case Studies
Figure 14. Leukemia Case Studies
Figure 15. Gynecological Cancer Case Studies
Figure 16. Other Case Studies
Figure 17. Anti-Neoplastic Pharmaceutical Agents Report Years Considered
Figure 18. Global Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth 2015-2026 (US$ Million)
Figure 19. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Regions: 2020 VS 2026
Figure 20. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Regions (2021-2026)
Figure 21. Porter's Five Forces Analysis
Figure 22. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Players in 2019
Figure 23. Global Top Anti-Neoplastic Pharmaceutical Agents Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Neoplastic Pharmaceutical Agents as of 2019
Figure 24. The Top 10 and 5 Players Market Share by Anti-Neoplastic Pharmaceutical Agents Revenue in 2019
Figure 25. North America Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Europe Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. China Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Japan Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. India Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2020) (Million US$)
Figure 31. Central & South America Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2020) (Million US$)
Figure 32. GlaxoSmithKline plc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. GlaxoSmithKline plc. Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
Figure 34. F. Hoffmann-La Roche Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
Figure 36. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Eli Lilly and Company Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
Figure 38. Bristol-Myers Squibb Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Bristol-Myers Squibb Company Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
Figure 40. Becton, Dickinson and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Becton, Dickinson and Company Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
Figure 42. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Pfizer Inc. Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
Figure 44. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Novartis AG Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
Figure 46. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. AstraZeneca Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
Figure 48. Gilead Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Gilead Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
